Exchange: NASDAQ·Updated 07:55 PM EDT

AEMD News

News
all
press releases
Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders?
Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders? Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
More News
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD) SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)PR NewswireNEW YORK, Sept. 18, 2026 NEW YORK, Sept. 18, 2026 /PRNewswire...
PR Newswire
Aethlon Medical Q1 2027 Earnings Call Transcript
Aethlon Medical (NASDAQ:AEMD) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data andread more...
Benzinga
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04read more...
Benzinga
Five Companies Enter the Spotlight with Big Catalysts
The small-cap market is heating up with a fresh wave of catalysts, as several companies put major developments in front of investors. Among the names drawing attention are Aethlon Medical (NASDAQ:AEMD), NeOnc Technologies Holdings (NASDAQ:NTHI), bioAffinity Technologies (NASDAQ:BIAF), Turbo Energy (NASDAQ:TURB), and Datasea Intelligent Technology (NASDAQ:DTSS).
24-7 Market News
AEMD Stock Alert: Halper Sadeh LLC is Investigating Whether Aethlon Medical, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Aethlon Medical, Inc. (NASDAQ: AEMD) and North Immunology, Inc. Upon closing of the proposed transaction, Aethlon shareholders are expected to own approximately 4.75% of the combined company.Halper Sadeh encourages...
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Aethlon Medical (NASDAQ:AEMD) shares increased by 382.5% to $6.9 during Thursday's pre-market session. The company's market cap stands at $1.0 million. Akanda (NASDAQ:AKAN) stock rose 15.07% to $3.13.read more...
Benzinga
AEMD’s Radical Reset Puts NOR-101 in the Spotlight
Aethlon Medical (NASDAQ:AEMD) is making a dramatic turn from medical-device developer to clinical-stage immunology company, announcing an all-stock merger with privately held North Immunology alongside an oversubscribed $180 million financing.
24-7 Market News
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic DermatitisPR NewswireSAN DIEGO and AUSTIN, Texas, Sept. 17...
PR Newswire
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular session. The company's market cap stands at $10.3 million. Aethlon Medical (NASDAQ:AEMD) shares moved upwards byread more...
Benzinga

Advertisement|Remove ads.